Product: Losartan (D6 Carboxylic Acid)
PLA2G6 Recombinant Protein Antigen Summary
| Description |
A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human PLA2G6.
Source: E.coli Amino Acid Sequence: QVLHTEVLQHLTDLIRNHPSWSVAHLAVELGIRECFHHSRIISCANCAENEEGCTPLHLACRKGDGEILVELVQYCHTQMDVTDYKGETVFHYAVQGDNSQVLQLLGRNAVAGLNQVNNQGLTPLHLACQLGKQEMVRVLLLCNARCNIMG |
| Protein/Peptide Type |
Recombinant Protein Antigen
|
| Gene |
PLA2G6
|
| Purity |
>80% by SDS-PAGE and Coomassie blue staining
|
Applications/Dilutions
| Dilutions |
|
| Application Notes |
This peptide is useful as a blocking peptide for NBP1-81586. Protein was purified by IMAC chromatography. The expected concentration is greater than 0.5 mg/ml. This product is produced on demand, estimated shipping date is 4 weeks after the order is placed.For further blocking peptide related protocol, click here.
|
| Theoretical MW |
34 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
Packaging, Storage & Formulations
| Storage |
Store at -20C. Avoid freeze-thaw cycles.
|
| Buffer |
PBS and 1M Urea, pH 7.4.
|
| Preservative |
No Preservative
|
| Purity |
>80% by SDS-PAGE and Coomassie blue staining
|
Alternate Names for PLA2G6 Recombinant Protein Antigen
- calcium-independent phospholipase A2
- EC 3.1.1.4
- Group VI phospholipase A2
- IPLA2
- iPLA285 kDa calcium-independent phospholipase A2
- IPLA2-VIA
- NBIA2A
- NBIA2B
- PARK14GVI
- patatin-like phospholipase domain containing 9
- phospholipase A2, group VI (cytosolic, calcium-independent)
- PNPLA9
